The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 355.00
Bid: 350.00
Ask: 354.00
Change: 8.00 (2.31%)
Spread: 4.00 (1.143%)
Open: 350.00
High: 355.00
Low: 346.00
Prev. Close: 347.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Doc re. (2022 Pillar 3 Disclosures)

5 Apr 2023 11:51

RNS Number : 4981V
Bank of Cyprus Holdings PLC
05 April 2023
 

Announcement

 

Pillar 3 Disclosures for the year ended 31 December 2022

 

 

Nicosia, 05 April 2023

 

Bank of Cyprus Holdings Public Limited Company (the "Company" or "BOC Holdings" and, together with its subsidiary, Bank of Cyprus Public Company Limited (the "Bank"), and the Bank's subsidiaries, the "Group"), announces today the publication of its Pillar 3 Disclosures for the year ended 31 December 2022 (the "Pillar 3 Report").

 

A copy of the Pillar 3 Report will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

The Pillar 3 Report is also available on the Group's website www.bankofcyprus.com (Group/Investor Relations).

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

Forward Looking Statements

 

This document contains certain forward-looking statements which can usually be identified by terms used such as "expect", "should be", "will be" and similar expressions or variations thereof or their negative variations, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements relating to the Group's near term, medium term and longer term future capital requirements and ratios, intentions, beliefs or current expectations and projections about the Group's future results of operations, financial condition, expected impairment charges, the level of the Group's assets, liquidity, performance, prospects, anticipated growth, provisions, impairments, business strategies and opportunities. By their nature, forward-looking statements involve risk and uncertainty because they relate to events, and depend upon circumstances, that will or may occur in the future. Factors that could cause actual business, strategy and/or results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements made by the Group include, but are not limited to: general economic and political conditions in Cyprus and other European Union (EU) Member States, interest rate and foreign exchange fluctuations, legislative, fiscal and regulatory developments, information technology, litigation and other operational risks, adverse market conditions, the impact of outbreaks, epidemics or pandemics, such as the COVID-19 pandemic and ongoing challenges and uncertainties posed by the COVID-19 pandemic for businesses and governments around the world. The Russian invasion of Ukraine has led to heightened volatility across global markets and to the coordinated implementation of sanctions on Russia, Russian entities and nationals. The Russian invasion of Ukraine has caused significant population displacement, and as the conflict continues, the disruption will likely increase. The scale of the conflict and the extent of sanctions, as well as the uncertainty as to how the situation will develop, may have significant adverse effects on the market and macroeconomic conditions, including in ways that cannot be anticipated. This creates significantly greater uncertainty about forward-looking statements. Should any one or more of these or other factors materialise, or should any underlying assumptions prove to be incorrect, the actual results or events could differ materially from those currently being anticipated as reflected in such forward-looking statements. The forward-looking statements made in this document are only applicable as at the date of publication of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this document to reflect any change in the Group's expectations or any change in events, conditions or circumstances on which any statement is based.

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. At 31 December 2022, the Bank of Cyprus Group operated through a total of 64 branches in Cyprus, of which 4 operated as cash offices. The Bank of Cyprus Group employed 2,889 staff worldwide. At 31 December 2022, the Group's Total Assets amounted to €25.4 bn and Total Equity was €2.1 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCBELFBXZLEBBB
Date   Source Headline
9th Aug 20221:26 pmRNSAmendment to Covered Bond Terms and Conditions
9th Aug 20227:04 amRNSDate of announcement of 1H2022 FR
25th Jul 20227:08 amRNSCompletion of Voluntary Staff Exit Plan
6th Jun 20227:00 amRNSTR1 Notification- Senvest
26th May 20227:00 amRNSTR1 Notification - Eaton Vance
23rd May 202210:35 amRNSBoard and Board Committees Composition
23rd May 20227:17 amRNSResolutions of AGM- Replacement
20th May 202212:36 pmRNSResolutions of AGM
19th May 20227:02 amRNSDoc re. (1Q2022 Financial Results Presentation)
19th May 20227:00 amRNS1st Quarter Results
5th May 20229:47 amRNSDate of announcement of 1Q2022 FR
14th Apr 20221:06 pmRNSNotice of AGM
13th Apr 202212:41 pmRNSPDMR Transaction - Ioardanou
7th Apr 202212:53 pmRNSPillar 3 Disclosures for 2021
4th Apr 20227:27 amRNSTR1 Notification of Major Holdings- Caius
30th Mar 202210:57 amRNSPDMR Notification of Transaction – Iordanou
30th Mar 20227:05 amRNSBOC Annual Financial Report 2021 Announcement
30th Mar 20227:03 amRNSBOCH Annual Financial Report 2021 Announcement
30th Mar 20227:02 amRNSDoc re. (FY2021 Investor Presentation)
30th Mar 20227:00 amRNSFY2021 Group Financial Results
18th Mar 202211:46 amRNSNotice of Results
17th Mar 20229:37 amRNSRestrictive measures and sanctions against Russia
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Feb 20227:02 amRNSDoc re. Prelim FY2021 Investor Presentation
21st Feb 20227:00 amRNSFY2021 Prel. Group FR and MT Strategic Targets
18th Feb 20228:22 amRNSTR1 Major Holdings Notification -Senvest
8th Feb 20227:00 amRNSDate of announcement of Preliminary Results 2021
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20211:22 pmRNSCompletion of a small-scale targeted VEP
16th Dec 202110:27 amRNSDate of Annual General Meeting
6th Dec 20217:43 amRNSEU-wide Transparency Exercise 2021
1st Dec 20217:00 amRNSDecision to call Tier 2 Capital Notes
30th Nov 202111:51 amRNSAppointment of New Director
30th Nov 202110:32 amRNSGroup Financial Results for 9M2021 - Replacement
30th Nov 20217:04 amRNSDoc re. (9M2021 Presentation Announcement)
30th Nov 20217:00 amRNSGroup Financial Results for 9M2021
19th Nov 20218:25 amRNSDate of Announcement of 9M2021 FR
15th Nov 20217:00 amRNSAgreement for sale of a portfolio of NPLs
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20214:35 pmRNSPrice Monitoring Extension
8th Oct 202112:10 pmRNSBuyback of Tier 2 Capital Notes
7th Oct 202111:57 amRNSAppointment of New Director
30th Sep 20218:32 amRNSTR-1 Notification- Caius
16th Sep 20217:33 amRNSTR-1 Notification -Senvest
13th Sep 202112:00 pmRNSTR-1 Notification - Carval
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.